Risk factors for the onset and progression of Huntington disease

被引:28
作者
Chao, Ting-Kuang [1 ]
Hu, Jing [2 ]
Pringsheim, Tamara [3 ]
机构
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[3] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
关键词
CAG REPEAT LENGTH; AGE-OF-ONSET; DNA HAPLOTYPE ANALYSIS; TRINUCLEOTIDE REPEAT; CLINICAL PROGRESSION; MOLECULAR ANALYSIS; COGNITIVE DECLINE; GENETIC-CHARACTERISTICS; INTERMEDIATE ALLELES; FUNCTIONAL DECLINE;
D O I
10.1016/j.neuro.2017.01.005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by chorea, behavioural and psychiatric manifestations, and dementia, caused by a CAG triplet repeat expansion in the huntingtin gene. Systematic review of the literature was conducted to determine the risk factors for the onset and progression of HD. Multiple databases were searched, using terms specific to Huntington disease and to studies of aetiology, risk, prevention and genetics, limited to studies on human subjects published in English or French between 1950 and 2010. Two reviewers independently screened the abstracts and identified potentially relevant articles for full-text review using predetermined inclusion criteria. Three major categories of risk factors for onset of HD were identified: CAG repeat length in the huntingtin gene, CAG instability, and genetic modifiers. Of these, CAG repeat length in the huntingtin gene is the most important risk factor. For the progression of HD: genetic, demographic, past medical/clinical and environmental risk factors have been studied. Of these factors, genetic factors appear to play the most important role in the progression of HD. Among the potential risk factors, CAG repeat length in the mutant allele was found to be a relatively consistent and significant risk factor for the progression of HD, especially in motor, cognitive, and other neurological symptom deterioration. In addition, there were many consistent results in the literature indicating that a higher number of CAG repeats was associated with shorter survival, faster institutionalization, and earlier percutaneous endoscopic gastrostomy. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:79 / 99
页数:21
相关论文
共 179 条
[1]   A systematic review of the intergenerational aspects and the diverse genetic profiles of Huntington's disease [J].
Agostinho, L. A. ;
dos Santos, S. R. ;
Alvarenga, R. M. P. ;
Paiva, C. L. A. .
GENETICS AND MOLECULAR RESEARCH, 2013, 12 (02) :1974-1981
[2]   DNA testing for Huntington disease in the Turkish population [J].
Akbas, F ;
Erginel-Unaltuna, N .
EUROPEAN NEUROLOGY, 2003, 50 (01) :20-24
[3]   Association between BDNF Val66Met polymorphism and age at onset in Huntington disease [J].
Alberch, J ;
López, M ;
Badenas, C ;
Carrasco, JL ;
Milà, M ;
Muñoz, E ;
Canals, JM .
NEUROLOGY, 2005, 65 (06) :964-965
[4]   ANCESTRAL DIFFERENCES IN THE DISTRIBUTION OF THE DELTA-2642 GLUTAMIC-ACID POLYMORPHISM IS ASSOCIATED WITH VARYING CAG REPEAT LENGTHS ON NORMAL CHROMOSOMES - INSIGHTS INTO THE GENETIC EVOLUTION OF HUNTINGTON DISEASE [J].
ALMQVIST, E ;
SPENCE, N ;
NICHOL, K ;
ANDREW, SE ;
VESA, J ;
PELTONEN, L ;
ANVRET, M ;
GOTO, J ;
KANAZAWA, I ;
GOLDBERG, YP ;
HAYDEN, MR .
HUMAN MOLECULAR GENETICS, 1995, 4 (02) :207-214
[5]   The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset [J].
Andresen, J. Michael ;
Gayan, Javier ;
Djousse, Luc ;
Roberts, Simone ;
Brocklebank, Denise ;
Cherny, Stacey S. ;
Cardon, Lon R. ;
Gusella, James F. ;
MacDonald, Marcy E. ;
Myers, Richard H. ;
Housman, David E. ;
Wexler, Nancy S. .
ANNALS OF HUMAN GENETICS, 2007, 71 :295-301
[6]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[7]   Genetic modifiers of Huntington's disease: beyond CAG [J].
Arning, Larissa ;
Epplen, Joerg T. .
FUTURE NEUROLOGY, 2012, 7 (01) :93-111
[8]   Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease [J].
Arning, Larissa ;
Haghikia, Aiden ;
Taherzadeh-Fard, Elahe ;
Saft, Carsten ;
Andrich, Juergen ;
Pula, Bartoz ;
Hoextermann, Stefan ;
Wieczorek, Stefan ;
Akkad, Denis Amer ;
Perrech, Moritz ;
Gold, Ralf ;
Epplen, Joerg Thomas ;
Chan, Andrew .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (04) :431-436
[9]   CAG REPEAT SIZE AND CLINICAL PRESENTATION IN HUNTINGTONS-DISEASE [J].
ASHIZAWA, T ;
WONG, LJC ;
RICHARDS, CS ;
CASKEY, CT ;
JANKOVIC, J .
NEUROLOGY, 1994, 44 (06) :1137-1143
[10]  
Ataç FB, 1999, ACTA NEUROL SCAND, V100, P195